Palak K. Parikh

477 total citations
24 papers, 329 citations indexed

About

Palak K. Parikh is a scholar working on Molecular Biology, Organic Chemistry and Hepatology. According to data from OpenAlex, Palak K. Parikh has authored 24 papers receiving a total of 329 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 4 papers in Organic Chemistry and 4 papers in Hepatology. Recurrent topics in Palak K. Parikh's work include Synthesis and biological activity (3 papers), Liver physiology and pathology (3 papers) and Multicomponent Synthesis of Heterocycles (3 papers). Palak K. Parikh is often cited by papers focused on Synthesis and biological activity (3 papers), Liver physiology and pathology (3 papers) and Multicomponent Synthesis of Heterocycles (3 papers). Palak K. Parikh collaborates with scholars based in India, United States and Canada. Palak K. Parikh's co-authors include Manjunath Ghate, Nisha I. Parikh, Charmy Kothari, Vivek K. Vyas, Snehal Patel, Vivek P. Chavda, Abu Sufiyan Chhipa, Vasso Apostolopoulos, Rajashri Bezbaruah and Dhrubo Jyoti Sen and has published in prestigious journals such as European Journal of Medicinal Chemistry, Current Medicinal Chemistry and Viruses.

In The Last Decade

Palak K. Parikh

21 papers receiving 322 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Palak K. Parikh India 8 155 63 56 50 42 24 329
Shourong Liu China 14 148 1.0× 57 0.9× 46 0.8× 42 0.8× 52 1.2× 52 457
Heba M. Eltahir Saudi Arabia 12 150 1.0× 32 0.5× 27 0.5× 32 0.6× 22 0.5× 32 379
Bhagyalakshmi Nair India 14 183 1.2× 57 0.9× 23 0.4× 40 0.8× 42 1.0× 36 511
Hafiz Muzzammel Rehman Pakistan 13 198 1.3× 33 0.5× 111 2.0× 49 1.0× 17 0.4× 62 480
Junjian Hu China 10 118 0.8× 60 1.0× 32 0.6× 59 1.2× 9 0.2× 15 385
Shenghao Li China 12 166 1.1× 17 0.3× 37 0.7× 33 0.7× 19 0.5× 33 373
Yasmin Badshah Pakistan 9 152 1.0× 29 0.5× 35 0.6× 12 0.2× 17 0.4× 35 306
Antonio Gil‐Gómez Spain 13 194 1.3× 131 2.1× 12 0.2× 26 0.5× 22 0.5× 35 539
Archie Thurston United States 12 166 1.1× 12 0.2× 27 0.5× 41 0.8× 29 0.7× 18 496

Countries citing papers authored by Palak K. Parikh

Since Specialization
Citations

This map shows the geographic impact of Palak K. Parikh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Palak K. Parikh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Palak K. Parikh more than expected).

Fields of papers citing papers by Palak K. Parikh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Palak K. Parikh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Palak K. Parikh. The network helps show where Palak K. Parikh may publish in the future.

Co-authorship network of co-authors of Palak K. Parikh

This figure shows the co-authorship network connecting the top 25 collaborators of Palak K. Parikh. A scholar is included among the top collaborators of Palak K. Parikh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Palak K. Parikh. Palak K. Parikh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Parikh, Palak K., et al.. (2025). Optimizing quality and sustainability in drug development: A comprehensive Desidustat stability study using QbD and green chemistry. Journal of Liquid Chromatography & Related Technologies. 48(16-20). 637–652.
2.
Vyas, Vivek K., et al.. (2024). Design, synthesis and pharmacological evaluation of novel thiazole derivatives as c-Met kinase inhibitors and anticancer agents. Journal of Molecular Structure. 1317. 139074–139074. 4 indexed citations
3.
Patel, Chirag, et al.. (2024). Inhibition of Uridine 5′-diphospho-glucuronosyltransferases A10 and B7 by vitamins: insights from in silico and in vitro studies. In Silico Pharmacology. 12(1). 8–8. 3 indexed citations
4.
Chavda, Vivek P., Palak K. Parikh, Abu Sufiyan Chhipa, et al.. (2023). Conventional and Novel Diagnostic Tools for the Diagnosis of Emerging SARS-CoV-2 Variants. Vaccines. 11(2). 374–374. 21 indexed citations
5.
Parikh, Palak K., et al.. (2023). Developments in small molecule antiviral drugs against hepatitis B and C viruses: FDA approved therapies and new drugs in clinical trials. Arabian Journal of Chemistry. 16(8). 105013–105013. 2 indexed citations
6.
Parikh, Palak K., et al.. (2023). Comprehensive Review on Analytical and Bioanalytical Methods for Quantification of Anti-angiogenic Agents used in Treatment of CervicalCancer. Current Pharmaceutical Analysis. 19(10). 735–744. 5 indexed citations
7.
Patel, Snehal, et al.. (2022). Future treatment of Diabetes – Tyrosine Kinase inhibitors. Journal of Diabetes & Metabolic Disorders. 22(1). 61–71. 2 indexed citations
8.
Chavda, Vivek P., Rajashri Bezbaruah, Palak K. Parikh, et al.. (2022). Replicating Viral Vector-Based Vaccines for COVID-19: Potential Avenue in Vaccination Arena. Viruses. 14(4). 759–759. 42 indexed citations
9.
Parikh, Palak K., et al.. (2021). Histone deacetylase 2: A potential therapeutic target for cancer and neurodegenerative disorders. European Journal of Medicinal Chemistry. 216. 113332–113332. 28 indexed citations
10.
Vyas, Vivek K., et al.. (2018). Medicinal Chemistry of Potassium Channel Modulators: An Update of Recent Progress (2011-2017). Current Medicinal Chemistry. 26(12). 2062–2084. 6 indexed citations
11.
Parikh, Palak K. & Manjunath Ghate. (2017). Recent advances in the discovery of small molecule c-Met Kinase inhibitors. European Journal of Medicinal Chemistry. 143. 1103–1138. 121 indexed citations
12.
Parikh, Palak K., Manjunath Ghate, & Vivek K. Vyas. (2015). CoMFA and CoMSIA studies on 6,7-disubstituted-4-phenoxyquinoline derivatives as c-Met kinase inhibitors and anticancer agents. Medicinal Chemistry Research. 24(12). 4078–4092. 7 indexed citations
13.
Parikh, Nisha I., Palak K. Parikh, & Charmy Kothari. (2014). Indigenous plant medicines for health care: treatment of Diabetes mellitus and hyperlipidemia. Chinese Journal of Natural Medicines. 12(5). 335–344. 43 indexed citations
15.
Parikh, Palak K., et al.. (2013). A novel approach for Arc-Flash detection and mitigation: At the speed of light and sound. 107–113. 3 indexed citations
16.
Parikh, Palak K., et al.. (2012). A novel approach for Arc-Flash detection and mitigation: At the speed of light and sound. 1–8. 6 indexed citations
17.
Parikh, Palak K., et al.. (2011). ALPHALISA BIOMARKER AS A TOOL OF DRUG DISCOVERY ANDDEVELOPMENT. International Journal of Drug Development and Research. 3(2). 1 indexed citations
18.
Parikh, Palak K., et al.. (2011). CHEMISTRY OF BIOACTIVE TRICYCLIC FUSED HETEROCYCLICRING HAVING ONE HETEROATOM. International Journal of Drug Development and Research. 3(2). 4 indexed citations
19.
Parikh, Palak K., et al.. (2011). SYNTHESIS AND BIOLOGICAL EVALUATION OF 1,3,4-OXADIAZOLEDERIVATIVES AS POTENTIAL ANTIBACTERIAL AND ANTIFUNGALAGENTS. International Journal of Drug Development and Research. 3(2). 3 indexed citations
20.
Parikh, Palak K., et al.. (2010). Dendrimer Nanocarriers as Versatile Vectors in Gene Delivery. Journal of chemical and pharmaceutical research. 2(3). 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026